Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peripheral nerve recovery refers to the multifaceted physiological process through which the peripheral nervous system (PNS) restores structure and function following traumatic injury or disease [3][4]. Unlike the central nervous system, the PNS demonstrates a robust capacity for regeneration, initiated by Wallerian degeneration of the distal nerve segment to clear inhibitory myelin debris [5][11]. This is followed by the reprogramming of Schwann cells into a specialized 'repair' phenotype that guides regrowing axons from the proximal stump toward their targets via the formation of the Bands of Büngner [5][8]. At the molecular level, this recovery is driven by the upregulation of various factors such as Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), and Glial cell line-derived neurotrophic factor (GDNF), which bind to receptors like TrkA and p75NTR to promote survival and axonal extension [6][10]. Therapeutic interventions being explored include small molecules like Rho-kinase inhibitors (e.g., Fasudil) and cell-cycle modulators (e.g., Roscovitine) to accelerate axonal outgrowth and improve functional reinnervation [7][9][10]. Despite its regenerative potential, peripheral nerve recovery is often slow and incomplete, frequently resulting in permanent muscle atrophy or neuropathic pain if the target organs are not reached in a timely manner [11][12]. This process is not a single molecular target but a coordinated biological response involving numerous receptors, enzymes, and signaling pathways [3][6].
Enhancement of peripheral nerve recovery involves multiple mechanisms of action depending on the specific molecule targeted, including the activation of neurotrophic factor receptors (e.g., TrkA, p75NTR, Ret) to stimulate survival and axonal outgrowth, the inhibition of Rho-kinase (ROCK) to prevent growth cone collapse, and the modulation of the inflammatory environment to facilitate macrophage-mediated debris clearance [6][7][10].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral nerve recovery.